Profil
Eric Bischoff worked as a Senior Vice President of Development & Operations at Rayzebio, Inc. and as a Vice President of Development & Operations at Metacrine, Inc. He also worked as a Senior Director of Operations at Seragon Pharmaceuticals, Inc. and as a Director of Operations at Aragon Pharmaceuticals, Inc. Bischoff completed his undergraduate degree at the University of California San Diego.
Ehemalige bekannte Positionen von Eric Bischoff
| Unternehmen | Position | Ende |
|---|---|---|
| RAYZEBIO, INC. | Geschäftsführer | 26.02.2024 |
| METACRINE, INC. | Geschäftsführer | 01.11.2020 |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Geschäftsführer | - |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Geschäftsführer | - |
Ausbildung von Eric Bischoff
| University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| METACRINE, INC. | Health Technology |
| RAYZEBIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
